|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Gluz, O.; Nitz, U.; Christgen, M.; Malter, W.; Clemens, M.; Reimer, T.; Nuding, B.; Aktas, B.; Stefek, A.; Ppllmanns, A.; Lorenz-Salehi, F.; Uleer, C.; Krabisch, P.; Kümmel, S.; Liedtke, C.; Shak, S.; Kates, R.; Würstlein, R.; Kreipe, H. H. und Harbeck, N.
(2017):
Prognostic impact of recurrence score (RS), grade/Ki67 central pathological review, and acycline (A)-free vs. A-containing chemotherapy (CT) on distant and locoregional disease-free survival (DDFS/LRFS) in high clinical risk HER2-early breast cancer (EBC): WSG PlanB trial results.
In: Annals of Oncology, Bd. 28
Gluz, O.; Nitz, U.; Christgen, M.; Kates, R.; Clemens, M.; Nuding, B.; Shak, S.; Würstlein, R.; Kreipe, H. und Harbeck, N.
(2017):
Five-year results of the prospective Phase III WSG PlanB trial confirm prognostic impact of 21-Gene Recurrence Score in high-risk HR+/HER2-early breast cancer (EBC) patients with 1-3 involved lymph nodes.
In: Breast, Bd. 32:
S93-S93
Liedtke, C.; Gluz, O.; Heinisch, F.; Feuerhake, F.; Kreipe, H. H.; Clemens, M.; Nuding, B.; Kraemer, S.; Reimer, T.; Svedman, C.; Shak, S.; Nitz, U.; Kates, R. E.; Harbeck, N. und Christgen, M.
(2016):
Association of TILs with clinical parameters, recurrence score, and prognosis in patients with early HER2-negative breast cancer (BC) A translational analysis of the prospective WSG planB trial.
In: Cancer Research, Bd. 76
Gluz, O.; Nitz, U.; Christgen, M.; Kates, R.; Clemens, M.; Kraemer, S.; Nuding, B.; Aktas, B.; Kuemmel, S.; Reimer, T.; Lorenz-Salehi, F.; Krabisch, P.; Just, M.; Augustin, D.; Liedtke, C.; Svedman, C.; Shak, S.; Wuerstlein, R.; Kreipe, H. und Harbeck, N.
(2016):
Prospective WSG phase III PlanB trial: Clinical outcome at 5 year follow up and impact of 21 Gene Recurrence Score result, central/local-pathological review of grade, ER, PR and Ki67 in HR+/HER2-high risk node-negative and -positive breast cancer.
In: European Journal of Cancer, Bd. 57:
S6-S6